This study identifies a #CDC20 inhibitor, Apcin, as a key molecular driver in #EndometrialCarcinoma that significantly suppresses #TumorProgression, thus opening new possibilities for targeted therapeutics approaches. #medsky

Read more: link.springer.com/article/10.1...